Showing results (421-430 of 582) with videos related to

Sort By:
Pageof 59
Biorxiv : the Preprint Server for Biology|July 3, 2023
A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptorHideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
European Journal of Pharmacology|July 11, 2002
Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brainRichard B Rothman, Marina Katsnelson, Nga Vu, et al.
The Journal of Biological Chemistry|June 27, 1997
Leptin receptor action in hepatic cellsY Wang, K K Kuropatwinski, D W White, et al.
Genomics|December 1, 1991
Characterization and functional expression of a cDNA encoding egasyn (esterase-22): the endoplasmic reticulum-targeting protein of beta-glucuronidaseM Ovnic, R T Swank, C Fletcher, et al.
Current Topics in Behavioral Neurosciences|November 11, 2016
Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsMichael H Baumann, Mohammad O Bukhari, Kurt R Lehner, et al.
ACS Chemical Neuroscience|February 12, 2024
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein SignalingMeng-Hua M Tsai, Li Chen, Michael H Baumann, et al.
Proceedings. Biological Sciences|November 20, 2015
Annual coral bleaching and the long-term recovery capacity of coralVerena Schoepf, Andréa G Grottoli, Stephen J Levas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2018
The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporterBrenda M Gannon, Michael H Baumann, Donna Walther, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2015
Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potencyRichard B Rothman, Subramaniam Ananthan, John S Partilla, et al.
Circulation|January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicationsR B Rothman, M H Baumann, J E Savage, et al.
Pageof 59